SanReno Therapeutics Overview
- Year Founded
-
2021
- Status
-
Acquired/Merged
- Employees
-
28
- Latest Deal Type
-
M&A
SanReno Therapeutics General Information
Description
Developer of biotech therapies focused on kidney diseases and related therapeutic areas. The company is committed to the research and development, production and commercialization of drugs in kidney diseases and related therapeutic areas, aiming to enable patients to improve qualities of living.
Contact Information
Website
www.sanreno.com(Operating Subsidiary)
Corporate Office
- Room 803B, Nanfung Building Number 1568
- Huashan Road
- Shanghai
- China
Corporate Office
- Room 803B, Nanfung Building Number 1568
- Huashan Road
- Shanghai
- China
SanReno Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Jan-2024 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series A) | 03-Dec-2021 | Completed | Clinical Trials - General | |||
| 1. Joint Venture | 03-Dec-2021 | Completed | Clinical Trials - General |
SanReno Therapeutics Comparisons
Industry
Financing
Details
SanReno Therapeutics Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Anji Pharma | Venture Capital-Backed | Cambridge, MA | ||||
| Ardelyx | Formerly VC-backed | Fremont, CA |
SanReno Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SanReno Therapeutics Executive Team (7)
| Name | Title | Board Seat |
|---|---|---|
| Annie Wu | Senior Vice President, Finance |
SanReno Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SanReno Therapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chinook Therapeutics | Corporation | Majority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| Pivotal BioVenture Partners (China) | Venture Capital | Minority | ||
| Samsara BioCapital | Venture Capital | Minority | ||
| Versant Ventures | Venture Capital | Minority |
SanReno Therapeutics FAQs
-
When was SanReno Therapeutics founded?
SanReno Therapeutics was founded in 2021.
-
Who is the founder of SanReno Therapeutics?
Haoyu Huang is the founder of SanReno Therapeutics.
-
Where is SanReno Therapeutics headquartered?
SanReno Therapeutics is headquartered in Shanghai, China.
-
What is the size of SanReno Therapeutics?
SanReno Therapeutics has 28 total employees.
-
What industry is SanReno Therapeutics in?
SanReno Therapeutics’s primary industry is Biotechnology.
-
Is SanReno Therapeutics a private or public company?
SanReno Therapeutics is a Private company.
-
What is SanReno Therapeutics’s current revenue?
The current revenue for SanReno Therapeutics is .
-
Who are SanReno Therapeutics’s investors?
Chinook Therapeutics, Frazier Healthcare Partners, Pivotal BioVenture Partners (China), Samsara BioCapital, and Versant Ventures have invested in SanReno Therapeutics.
-
Who are SanReno Therapeutics’s competitors?
Anji Pharma and Ardelyx are competitors of SanReno Therapeutics.
-
When was SanReno Therapeutics acquired?
SanReno Therapeutics was acquired on 05-Jan-2024.
-
Who acquired SanReno Therapeutics?
SanReno Therapeutics was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
